SOURCE: Universal Detection Technology

March 19, 2008 16:00 ET

Universal Detection Technology Receives First Purchase Order for Bioterrorism Detection Devices From China

Kits Provide Detection of Anthrax, Ricin, and Other Toxins

LOS ANGELES, CA--(Marketwire - March 19, 2008) - Universal Detection Technology (www.udetection.com) (OTCBB: UDTT) (FRANKFURT: PO8), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, announced today that it has received a purchase order from its Chinese distributor for bioterrorism detection kits.

The purchase order has been placed by Kadinuo Science and Technology in Beijing. Kadinuo Science and Technology has been active in introduction and promotion of advanced radiation instruments in the Chinese market for over 10 years. Presently, the company is a strong regional supplier of emergency nuclear monitors, environmental radiation monitors, decontamination technologies, and the like.

"We are very pleased to have received our first purchase order for these products from China. This is obviously a very large market and like any other has security concerns, relating to threat of Biological Weapons and Toxins and we are glad to be providing our solutions in countering these threats," said Jacques Tizabi, CEO of Universal Detection Technology.

There have been recent reports of terrorist activity in China. The Chinese Government has warned that terrorists pose the biggest risk to this summer's Olympic Games in Beijing. Officials say they foiled two plots, one to bring down an airliner, and another to disrupt the summer games. The Chinese government has also stepped up efforts in bio-security to ward off possible bioterrorism during the coming Olympics.

A biological attack can be carried out by a single individual that aims to disrupt society. The latest ricin incident in Las Vegas illustrates how a terrorist equipped with just an anarchist handbook and castor beans made one of the deadliest poisons known to man with the intend to cause harm.

UDTT is a supplier of counter terrorism services and technologies to private and government organizations. The Company owns the license to a patented technology developed at NASA's JPL and utilized in UDTT's BSM-2000 used for autonomous monitoring of the air for presence of airborne bacterial spores such as anthrax. UDTT also supplies detection kits for detection of up to 5 bioterrorism agents. Among the Company's other products are radiation detection systems, educational material & training DVDs, and antimicrobial chemicals.

UDTT's BSM-2000 and other bioterrorism and radiation detection technologies are anticipated to be a great match for Kadinuo's present products and services. Kadinuo has established relationships with more than 200 customers in China including government administrators, such as the Chinese State Environmental Protection Administration, Chinese Center for Disease Control and Prevention, Administration of Quality Supervision, Inspection and Quarantine of China, and the Public Security Bureau. In 2006 and 2007, Kadinuo has won 13 and 16 government bids respectively.

For more information please visit www.udetection.com or

Email us at info@udetection.com

About Universal Detection Technology

Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The Company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, the Company, in cooperation with NASA, has developed a bioterror 'smoke' detector that detects certain biohazard substances. For more information, please visit http://www.udetection.com.

Forward-Looking Statements

Except for historical information contained herein, the statements in this news release are forward-looking statements that involve known and unknown risks and uncertainties, which may cause the Company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.

Contact Information